OBJECTIVE: To compare outcomes of a pediatric cohort of patients compared with a matched cohort of adult patients, all diagnosed as having squamous cell carcinoma (SCC) of the oral tongue. Outcomes of oral cancer in pediatric patients have not been studied, to our knowledge. DESIGN: Retrospective matched-pair cohort study. SETTING: Memorial Sloan-Kettering Cancer Center, New York, New York. PATIENTS: A total of 10 pediatric and 40 adult patients diagnosed as having SCC of the oral tongue. MAIN OUTCOME MEASURES: Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS). RESULTS: The 5-year OS was equivalent in the 2 groups: 70% in the pediatric group and 64% in the adult group (P = .97). The 5-year DSS was also equivalent: 80% in the pediatric group and 76% in the adult group (P = .90). The 5-year RFS was 70% in the pediatric group and 78% in the adult group (P = .54). CONCLUSIONS: When pediatric and adult patients were matched for sex, tobacco use history, TNM status, surgical procedure, and adjuvant radiotherapy, outcomes for OS, DSS, and RFS were equivalent. Pediatric patients with SCC of the oral tongue should be treated similarly to adult patients.
OBJECTIVE: To compare outcomes of a pediatric cohort of patients compared with a matched cohort of adult patients, all diagnosed as having squamous cell carcinoma (SCC) of the oral tongue. Outcomes of oral cancer in pediatricpatients have not been studied, to our knowledge. DESIGN: Retrospective matched-pair cohort study. SETTING: Memorial Sloan-Kettering Cancer Center, New York, New York. PATIENTS: A total of 10 pediatric and 40 adult patients diagnosed as having SCC of the oral tongue. MAIN OUTCOME MEASURES: Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS). RESULTS: The 5-year OS was equivalent in the 2 groups: 70% in the pediatric group and 64% in the adult group (P = .97). The 5-year DSS was also equivalent: 80% in the pediatric group and 76% in the adult group (P = .90). The 5-year RFS was 70% in the pediatric group and 78% in the adult group (P = .54). CONCLUSIONS: When pediatric and adult patients were matched for sex, tobacco use history, TNM status, surgical procedure, and adjuvant radiotherapy, outcomes for OS, DSS, and RFS were equivalent. Pediatricpatients with SCC of the oral tongue should be treated similarly to adult patients.
Authors: S Soni; E Radel; R V Smith; M Edelman; R Sattenberg; S Wadler; J J Beitler Journal: J Pediatr Hematol Oncol Date: 2001-12 Impact factor: 1.289
Authors: Gerry F Funk; Lucy Hynds Karnell; Robert A Robinson; Weining K Zhen; Douglas K Trask; Henry T Hoffman Journal: Head Neck Date: 2002-02 Impact factor: 3.147
Authors: Karin Annertz; Harald Anderson; Anders Biörklund; Torgil Möller; Saara Kantola; Jon Mork; Jörgen H Olsen; Johan Wennerberg Journal: Int J Cancer Date: 2002-09-01 Impact factor: 7.396